These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33661186)

  • 61. Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds.
    Guo W; Xu Q
    J Pharmacol Sci; 2020 Nov; 144(3):139-146. PubMed ID: 32921395
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia: A Potential Mechanism of Resistance to Checkpoint Inhibition.
    Dibbern ME; Bullock TN; Jenkins TM; Duska LR; Stoler MH; Mills AM
    Am J Surg Pathol; 2020 Sep; 44(9):1184-1191. PubMed ID: 32496434
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PTPN11 (SHP2) Is Indispensable for Growth Factors and Cytokine Signal Transduction During Bovine Oocyte Maturation and Blastocyst Development.
    Idrees M; Xu L; Song SH; Joo MD; Lee KL; Muhammad T; El Sheikh M; Sidrat T; Kong IK
    Cells; 2019 Oct; 8(10):. PubMed ID: 31635340
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comprehensive review of SHP2 and its role in cancer.
    Asmamaw MD; Shi XJ; Zhang LR; Liu HM
    Cell Oncol (Dordr); 2022 Oct; 45(5):729-753. PubMed ID: 36066752
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long non-coding RNA FAM239A promotes tumor cell proliferation and migration by regulating tyrosine phosphatase Src homology 2 domain-containing phosphatase 2 in head and neck squamous cell carcinoma.
    Li Y; Guo Y; Liu Z; Mou Y; Fang H; Yang Y; Zhao X; Zhang H; Song X
    Arch Oral Biol; 2023 Mar; 147():105615. PubMed ID: 36630765
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application.
    Yuan X; Bu H; Zhou J; Yang CY; Zhang H
    J Med Chem; 2020 Oct; 63(20):11368-11396. PubMed ID: 32460492
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.
    LaMarche MJ; Acker M; Argintaru A; Bauer D; Boisclair J; Chan H; Chen CH; Chen YN; Chen Z; Deng Z; Dore M; Dunstan D; Fan J; Fekkes P; Firestone B; Fodor M; Garcia-Fortanet J; Fortin PD; Fridrich C; Giraldes J; Glick M; Grunenfelder D; Hao HX; Hentemann M; Ho S; Jouk A; Kang ZB; Karki R; Kato M; Keen N; Koenig R; LaBonte LR; Larrow J; Liu G; Liu S; Majumdar D; Mathieu S; Meyer MJ; Mohseni M; Ntaganda R; Palermo M; Perez L; Pu M; Ramsey T; Reilly J; Sarver P; Sellers WR; Sendzik M; Shultz MD; Slisz J; Slocum K; Smith T; Spence S; Stams T; Straub C; Tamez V; Toure BB; Towler C; Wang P; Wang H; Williams SL; Yang F; Yu B; Zhang JH; Zhu S
    J Med Chem; 2020 Nov; 63(22):13578-13594. PubMed ID: 32910655
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
    Skov S; Bregenholt S; Claesson MH
    J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative analysis of protein phosphorylations and interactions by multi-colour IP-FCM as an input for kinetic modelling of signalling networks.
    Deswal S; Schulze AK; Höfer T; Schamel WW
    PLoS One; 2011; 6(7):e22928. PubMed ID: 21829558
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4.
    Cooke M; Orlando U; Maloberti P; Podestá EJ; Cornejo Maciel F
    J Lipid Res; 2011 Nov; 52(11):1936-48. PubMed ID: 21903867
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SHP2 regulates proliferation and tumorigenicity of glioma stem cells.
    Roccograndi L; Binder ZA; Zhang L; Aceto N; Zhang Z; Bentires-Alj M; Nakano I; Dahmane N; O'Rourke DM
    J Neurooncol; 2017 Dec; 135(3):487-496. PubMed ID: 28852935
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers.
    Hao HX; Wang H; Liu C; Kovats S; Velazquez R; Lu H; Pant B; Shirley M; Meyer MJ; Pu M; Lim J; Fleming M; Alexander L; Farsidjani A; LaMarche MJ; Moody S; Silver SJ; Caponigro G; Stuart DD; Abrams TJ; Hammerman PS; Williams J; Engelman JA; Goldoni S; Mohseni M
    Mol Cancer Ther; 2019 Dec; 18(12):2368-2380. PubMed ID: 31439712
    [No Abstract]   [Full Text] [Related]  

  • 73. Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC.
    Tang KH; Li S; Khodadadi-Jamayran A; Jen J; Han H; Guidry K; Chen T; Hao Y; Fedele C; Zebala JA; Maeda DY; Christensen JG; Olson P; Athanas A; Loomis CA; Tsirigos A; Wong KK; Neel BG
    Cancer Discov; 2022 Jan; 12(1):47-61. PubMed ID: 34353854
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Correlation and clinical significance of VISTA expression and cervical squamous cell carcinoma].
    Li L; Wang LL; Zhou JY
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):396-401. PubMed ID: 37188624
    [No Abstract]   [Full Text] [Related]  

  • 75. Silencing ZAP70 prevents HSP65-induced reverse cholesterol transport and NF-κB activation in T cells.
    Hu J; Luo T; Xi D; Guo K; Hu L; Zhao J; Chen S; Guo Z
    Biomed Pharmacother; 2018 Jun; 102():271-277. PubMed ID: 29567540
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SHP2 positively regulates TGFβ1-induced epithelial-mesenchymal transition modulated by its novel interacting protein Hook1.
    Li S; Wang L; Zhao Q; Liu Y; He L; Xu Q; Sun X; Teng L; Cheng H; Ke Y
    J Biol Chem; 2014 Dec; 289(49):34152-60. PubMed ID: 25331952
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ZAP70 expression in regulatory T cells in allergic rhinitis: effect of immunotherapy.
    Ciebiada M; Kasztalska K; Gorska-Ciebiada M; Górski P
    Clin Exp Allergy; 2013 Jul; 43(7):752-61. PubMed ID: 23786282
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Deregulation of hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling pathways promotes the proliferation of oral squamous carcinoma cells by synergistically activating SHP2/PLK1 signals.
    Jun W; Shaobo O; Xianhua Z; Siyu Z; Mingyang C; Xin F; Ying C; Lan L
    Sci Rep; 2021 Oct; 11(1):20561. PubMed ID: 34663837
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    Valencia-Sama I; Ladumor Y; Kee L; Adderley T; Christopher G; Robinson CM; Kano Y; Ohh M; Irwin MS
    Cancer Res; 2020 Aug; 80(16):3413-3423. PubMed ID: 32586982
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD8 T cell sensory adaptation dependent on TCR avidity for self-antigens.
    Marquez ME; Ellmeier W; Sanchez-Guajardo V; Freitas AA; Acuto O; Di Bartolo V
    J Immunol; 2005 Dec; 175(11):7388-97. PubMed ID: 16301646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.